MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
131.68
+0.13
+0.10%
After Hours: 131.00 -0.68 -0.52% 19:46 02/13 EST
OPEN
131.75
PREV CLOSE
131.55
HIGH
132.14
LOW
128.27
VOLUME
593.73K
TURNOVER
--
52 WEEK HIGH
134.19
52 WEEK LOW
64.11
MARKET CAP
6.38B
P/E (TTM)
-20.1484
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1d ago
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NASDAQ · 1d ago
Axsome Therapeutics Is Maintained at Overweight by Wells Fargo
Dow Jones · 1d ago
Wells Fargo Maintains Overweight on Axsome Therapeutics, Raises Price Target to $160
Benzinga · 1d ago
Axsome Therapeutics price target raised to $160 from $140 at Wells Fargo
TipRanks · 1d ago
Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade
Seeking Alpha · 2d ago
Axsome Therapeutics Price Target Announced at $176.00/Share by Deutsche Bank
Dow Jones · 2d ago
Deutsche Bank Initiates Coverage On Axsome Therapeutics with Buy Rating, Announces Price Target of $176
Benzinga · 2d ago
More
About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and delivering therapies for central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity under development for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. AXS-07 is an oral, rapidly absorbed, multi-mechanistic, investigational medicine under development for the acute treatment of migraine.

Webull offers Axsome Therapeutics Inc stock information, including NASDAQ: AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.